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INTRODUCTION 
Fast dissolving tablets (FDT) are solid single-unit dosage 
forms that are placed in the mouth, allowed to 
disperse/dissolve in the saliva and then swallowed without 
the need for water. FDT’s are not only indicated for people 
who have swallowing difficulties, but also are ideal for 
active people. FDT’s are those when put on tongue 
disintegrates instantaneously releasing the drug, which 
dissolves or disperse in saliva
1
.  
Salbutamol sulphate is a short-acting ß2-adrenergic 
receptor agonist used for the relief of bronchospasm in 
conditions such as asthma and COPD. (Chronic 
Obstructive Pulmonary Disease). Salbutamol is well 
absorbed from the gastrointestinal tract having 50% oral 
bioavailability due to first pass metabolism. Hence an 
attempt was made for preparing fast dissolving tablet of 
salbutamol sulphate and compares along with natural and 
synthetic superdisintegrants. With an aim of reducing the 
lag time and providing faster onset of action to relieve 
immediately acute asthmatic attack. This would be 
advantageous as conventional solid oral dosage forms are 
often associated with first pass effect, longer lag time and 
slower onset of action but require careful handling. 
Aerosol systems are specific but fail to deliver actual dose 
of drug with only 10 % of administered dose deposited on 
the bronchi while rest of the drug is deposited in 
oropharynx and is swallowed. Also, metered dose system 
are less potable while dry powder inhalers cause clogging 
of device and require skilful operation. FDT’s would be 
advantageous, as salbutamol sulphate is water soluble and 
its preparation into FDT’s would render it to dissolve 
rapidly and thereby result in  rapid absorption improved 
oral bioavailability without any lag time
2
. 
Various natural substances have been used in the 
formulations of FDT’s. Mucilage of natural origin is 
preferred over semi-synthetic and synthetic substances 
because they are comparatively cheaper, abundantly 
available, non-irritating and nontoxicin nature. In the 
present investigation, the preparation and evaluation of fast 
dissolving tablets by using different concentrations of 
natural superdisintegrant that is Plantago ovata mucilage 
is studied. The reasons for selection of Plantago ovata 
mucilage because it’s high swelling index. Mucilage of 
Plantago ovata has various characteristics like binding, 
disintegrating and sustaining properties. Hence, in present 
study, mucilage of Plantago ovata was used to develop 
FDT’s of salbutamol sulphate. The concept of formulating 
FDT’s of salbutamol sulphate increases the water uptake 
with shortest wetting time and there by decrease the 
disintegration time of the tablets by simple and cost 
effective direct compression techniques
3, 4
. 
MATERIALS AND METHODS 
Materials: 
Salbutamol Sulphate was gifted by Glenmark 
Pharmaceuticals Ltd. Nashik. Plantago ovata seeds were 
purchased from local market Mumbai. Plantago ovata 
husk powder was obtained as a gift sample from Gayatri 
Psyllium husk powder, Unjha Gujarat. Crosscarmellose 
sodium, Sodium starch glycolate, Microcrystalline 
cellulose, Mannitol, Colloidal silicon dioxide, Talc, 
Aspartame and Vanillin used were of analytical grades. 
Methods: 
Formulation of  FDT’s by direct compression method: 
Salbutamol sulphate, directly compressible 
(microcrystalline cellulose), superdisintegrants 
(POM/POH/croscarmellose sodium/sodium starch 
glycolate), colloidal silicon dioxide, mannitol, were sifted 
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through the sieve #44 and admixed for about 15 minutes to 
make a uniform blend. Talc, aspartame, vanillin were 
passed through sieve #100 and mixed with the above blend 
for approximately 5-7 minutes. The blend was evaluated 
for precompression parameters. The resulting uniform 
blends were directly compressed using 6mm, round 
convex faced tooling to make the tablets using 10 station 
compression machine (Rimek, Mini Press-1, Karnavati 
Engineering Limited). The tablet press setting was kept 
constant across all formulations.  
STANDARD CALIBRATION CURVE 
The solutions of salbutamol sulphate in the range of 60-
100 μg/ml and 20-100 μg/ml in phosphate buffer pH 6.8 
and distilled water were prepared respectively. Absorbance 
was measured for each solution at λmax of 276.4 nm and 
275nm respectively, using UV-Vis Spectrophotometer 
(Jasco- V630, Japan). 
AUTHENTICATION OF Plantago ovata SEEDS 
The seeds of Plantago ovata were authenticated from 
Botany Department NDMVP’s junior college, Nashik. The 
authentication results proves that the seeds are of Plantago 
ovata belonging to family Plantaginaceae. 
METHODOLOGY FOR ISOLATION OF 
MUCILAGE 
Seeds of Plantago ovata were soaked in distilled water for 
48 hrs. Soaked seeds were boiled for 120 minutes till 
mucilage get released into the water completely. As soon 
as mucilage gets released the mucilage was squeezed out 
and separated from seeds with the help of nylon muslin 
cloth. The mucilage collected and precipitated using 95% 
ethanol (1: 2) and washed twice with the same. Collected 
mucilage was dried in the tray dryer at 50-55°C. Dried 
mucilage was scraped and powdered using mortar and 
pestle. This crushed and fine powder was then passed 
through # 80. The mucilage was then kept in dessicator 
until its use
5
. 
Physicochemical and Phytochemical evaluation of dried 
powdered mucilage
6, 7, 8 
Organoleptic properties 
Organoleptic properties such as physical appearance, 
colour, odour and taste of dried powdered mucilage were 
determined. 
Solubility profile  
The solubility of dried powdered mucilage was checked by 
adding a pinch in the solvent such as water. 
Charring  
A few milligrams of dried mucilage powder and husk 
powder were placed in a melting-point apparatus. The 
temperature was taken and recorded when the material 
started to char. 
pH determination 
The pH values of solutions prepared in specified strength 
were determined using calibrated (pH 4 and pH 7) digital 
pH meter. 
Preliminary phytochemical screening 
A preliminary phytochemical screening of dried powdered 
mucilage was carried out for the detection of various 
phytoconstituents.  
Ash values (WHO GUIDELINES) 
Total ash, acid-insoluble ash, water-soluble ash, sulphated 
ash values were evaluated. 
Loss on Drying 
Loss on Drying was determined for an appropriate quantity 
of dried powdered mucilage at 105
o
C for 5 hours.  
LOD (%) = (Wt of water in sample/Wt of dry sample) x 100 
 
Swelling power 
The swelling power of the dried mucilage powder was 
performed as outlined in Indian Pharmacopoeia. 
Viscosity determination 
Rheological studies of dried mucilage were carried out 
using varying concentrations (0.1–0.5w/v) prepared in 
distilled water. The viscosities were measured using a 
Brookfield viscometer spindle no.62 at 100 rpm at 25
o
C. 
Microbial count 
The microbial count of the dried mucilage powder was 
performed as outlined in Indian Pharmacopoeia for the 
presence of bacteria as well as for fungi. Total count of 
bacteria and fungi was calculated using plate count 
method. 
Particle size determination 
The particle size of the dried-powder mucilage and husk 
powder were determined by the microscopic method. 
Hydation capacity (water retention capacity) 
1gm of dried-powder mucilage was placed in a centrifuge 
tube and covered with 10 mL of distilled water. The tube 
was shaken intermittently over 2 hours and left to stand for 
10 minutes at 3000 rpm. With the supernatant decanted 
and the weight of the powder after water uptake and 
centrifugation, x was determined.  
 
Hydration capacity= x / y 
 
Where x is the weight of moist powder after centrifugation 
and y is the weight of dry powder respectively. 
 
Flow properties of dried mucilage powder 
The flow properties of dried mucilage powder were 
characterized.  
Drug excipients Compatibility studies
 
Fourier Transform Infra-Red Spectroscopy (FTIR) 
The drug and physical mixture of drug and excipients were 
subjected to IR spectroscopic study using FT-IR 
spectrophotometer (Bruker Alpha ATR).  
Differential Scanning Calorimetry 
Thermogram of drug and physical mixture (drug: POM); 
(ratio1:5) were employed (DSC60 SHIMADZU) for the 
determination of glass transition temperature (Tg).  
Assignment of formulation code  
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Various formulations of Salbutamol sulphate (API) fast 
dissolving tablets(FDTs) were designed utilizing natural 
superdisintegrants as mucilage of Plantago ovata (POM), 
husk of Plantago ovata (POH) and synthetic 
superdisintegrants as Crosscarmelose sodium(CCS), 
Sodium starch glycolate (SSG) each varied at different 
concentrations (2, 4, 6, 8 and 10 %). All of the other 
ingredients were kept constant. A total of such fifteen 
formulations prepared were designated with their codes 
and will be referred with the same in further sections. The 
assigned formulation codes were as follows: SM1, SM2, 
SM3, SM4 and SM5 for formulations containing mucilage 
of Plantago ovata and SH1, SH2, SH3, SH4 and SH5 for 
formulations containing husk of Plantago ovata as a 
superdisintegrant with concentrations 2, 4, 6, 8 and 10 % 
respectively. Similarly, SC1, SC2, SC3, SC4 and SC5 also 
SS1, SS2, SS3, SS4 and SS5 were the assigned codes for 
the formulations prepared with crosscarmellose sodium, 
Sodium starch glycolate as superdisintegrants at the 
percentage levels provided for PO above. 
Evaluation of fast dissolving tablets
9, 10 
Weight variation 
Twenty tablets were selected randomly from each 
formulation and weighed individually. The individual 
weights were compared with the average weight for the 
weight variation. 
Hardness and Friability 
Hardness of the tablets was measured using the Monsanto 
hardness tester. The friability of a sample of twenty tablets 
was measured using a USP type Roche friabilator. Pre-
weighed tablets were placed in a plastic chambered 
friabilator attached to a motor revolving at a speed of 25 
rpm for 4 min. The friability was calculated. 
Drug content uniformity 
For the content uniformity test, twenty tablets were 
weighed and pulverized to a fine powder. A quantity of 
powder equivalent to 4mg of salbutamol sulphate was 
taken in 100ml volumetric flask containing distilled water. 
An aliquot of 2ml sample was withdrawn and diluted to 
10ml and analysed by UV spectrophotometer at 275nm 
against blank. Then the amount of drug present was 
calculater using standard calibration curve. The mean 
percent drug content was calculated as an average of three 
determinations. 
In vitro disintegration time 
Six tablets were placed individually in each tube of 
disintegration test apparatus and discs were placed. 
Distilled water was maintained at a temperature of 
37°±2°C and time taken for the entire tablet to disintegrate 
completely was noted. 
Wetting time and water absorption ratio (R) 
Twice folded tissue paper was placed in a Petri dish having 
an internal diameter of 6.5 cm to that added 6 ml of 
purified water. A tablet was carefully placed on the surface 
of the tissue paper in the Petri dish. The time required for 
water to reach the upper surface of the tablet and to 
completely wet it was noted as the wetting time. Water 
absorption ratio (R) was then determined according to the 
following equation: 
R=[(Wa-Wb) /Wb] x100 
 
Where; Wb and Wa were tablet weights before and after 
water absorption, respectively. 
In vitro drug release study 
In vitro dissolution of the tablets was determined using 
USP- Type-II dissolution test apparatus rotating at 50 rpm 
in 900 ml pH6.8 phosphate buffer solution as medium 
maintained at 37±0.5 ºC.The amount of drug in solution 
was determined spectrophotometrically at 276.4 nm.  
Stability study 
The fast dissolving tablets were packed in aluminium foil 
and stored under the following environmental conditions 
for a period as prescribed by ICH guidelines for 
accelerated studies at 40
o
C and 75% RH. The tablets were 
withdrawn at end of 90 days and evaluated for parameters 
including disintegration time, drug content and dissolution 
study. 
RESULT AND DISCUSSION 
Phytochemical, microbial and physicochemical 
characterization of Plantago ovata mucilage 
Organoleptic properties 
It is creamish fine powder odourless with mucilaginous 
taste. 
Solubility profile 
Mucilage does not dissolve in water, it swells. 
Table 1: Charring and pH determination of dried 
mucilage powder 
Charring 
Dried mucilage powder Husk powder 
183-184°C 182-183°C 
pH determination 
0.5% solution 6.2 
 
Table 2: Preliminary phytochemical screening 
Tests Observations Inferences 
Ruthenium test 
Take a small quantity of 
dried mucilage powder, 
mount it on a slide with 
ruthenium red solution and 
observe it under 
microscope. 
 
Pink colour 
develops 
 
Mucilage 
is present 
 
Dried mucilage powder 
 
 
Aqueous 
potassium 
hydroxide 
 
Swells 
 
Patni et al                                      Journal of Drug Delivery & Therapeutics; 2013, 3(5), 22-30    25 
© 2011, JDDT. All Rights Reserved                                                       ISSN: 2250-1177                                                      CODEN (USA): JDDTAO 
The presence of mucilage was confirmed using ruthenium 
red and aqueous potassium hydroxide. Both tests were 
positive. 
 
Table 3: Physical properties of dried powder mucilage 
Identification tests Observed results Reported standards 
(BP 1988, IP 1996) 
Ash value  Not More Than 4.5% 
Total ash (%) 3.46 - 
Acid-insoluble ash (%) 0.33 Not More Than  0.45% 
Water soluble ash (%) 2.0 - 
Sulphated ash(gm) 0.149  - 
Loss on Drying (%) 11.25 Not More Than 12.0% determined on 0.5 g 
Swelling power(ml) 42 Not Less Than 40ml 
Viscosity(cp) 8.42 for 0.3% solution - 
Microbial count (cfu/g) 
For bacteria 
For fungi 
 
6 
3 
- 
Particle-size determination (µm) 
Dried mucilage powder 
Husk powder 
 
150-200 
150-200 
- 
Hydration capacity 9.5 - 
Bulk density (g/ml) 0.49 - 
Tapped density (g/ml) 0.56 - 
Carr’s index (%) 12.745 - 
Hausner’s ratio 1.142 - 
Angle of repose (
o
) 29.05 - 
 
Drug excipients Compatibility studies 
 
 
Figure 1: IR Spectrum of Salbutamol sulphate 
 
 
Figure 2:  FTIR spectra of Drug + POM 
 
           Sr.No. Functional groups Pure drug POM Pure drug + POM 
1 C-O(alkyl, aryl) Yes Yes Yes 
2 N=O(aromatic nitroso group) Yes Yes Yes 
3 C-H(bending) Yes Yes Yes 
4 P=O 
(phosphine oxide ) 
Yes Yes Yes 
5 O-H  (bending) Yes Yes Yes 
Figure 1 and 2 represents the FTIR spectra of pure drug and drug + POM which were found to contain the same peaks as 
that found in pure drug, and no any additional peak was observed in physical mixture revealing that no incompatibility 
exist between them. 
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  Figure 3: DSC thermogram of Salbutamol sulphate 
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Figure 4: DSC of drug with POM 
DSC thermograms of drug and its physical mixture exhibited a sharp endothermic peak at 226.76
o
C and at 226.98
o
C then 
the intensity was reduced and the peak slightly shifted to 256.29
o
C respectively revealing that no incompatibility exist 
between them. 
 
Table 4: Composition of formulation batches for fast dissolving tablet of Salbutamol sulphate having weight 100mg 
Ingredients(m
g) 
                                                  
 
 
Formulation 
      Code 
Salbutam
ol 
Sulphate 
PO
M 
PO
H 
CC
S 
SS
G 
Tal
c 
MC
C 
Colloid
al SiO2 
Mannit
ol 
Aspartam
e 
Vanilli
n 
SM1 4 2 - - - 2 35 0.5 50 4 2 
SM2 4 4 - - - 2 33 0.5 50 4 2 
SM3 4 6 - - - 2 31 0.5 50 4 2 
SM4 4 8 - - - 2 29 0.5 50 4 2 
SM5 4 10 - - - 2 27 0.5 50 4 2 
SH1 4 - 2 - - 2 35 0.5 50 4 2 
SH2 4 - 4 - - 2 33 0.5 50 4 2 
SH3 4 - 6 - - 2 31 0.5 50 4 2 
SH4 4 - 8 - - 2 29 0.5 50 4 2 
SH5 4 - 10 - - 2 27 0.5 50 4 2 
SC1 4 - - 2 - 2 35 0.5 50 4 2 
SC2 4 - - 4 - 2 33 0.5 50 4 2 
SC3 4 - - 6 - 2 31 0.5 50 4 2 
SC4 4 - - 8 - 2 29 0.5 50 4 2 
SC5 4 - - 10 - 2 27 0.5 50 4 2 
SS1 4 - - - 2 2 35 0.5 50 4 2 
SS2 4 - - - 4 2 33 0.5 50 4 2 
SS3 4 - - - 6 2 31 0.5 50 4 2 
SS4 4 - - - 8 2 29 0.5 50 4 2 
SS5 4 - - - 10 2 27 0.5 50 4 2 
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Table 5: Evaluation of blend for formulation batches 
Formulation 
Code 
Bulk Density 
(g/ml) 
± S.D 
Tapped Density 
(g/ml) 
± S.D 
Carr’s 
Index (%) 
± S.D 
Hausner’s 
Ratio 
± S.D 
Angle of repose 
(
o
) 
± S.D 
Flow 
ability 
SM1 0.680± 0.007 0.782± 0.007 12.995±1.235 1.149±0.014 24.593± 1.120 
 
Excellent 
SM2 
 
0.590± 0.010 0.672± 0.006 12.107±2.119 1.138 ±0.027 23.311±1.675 
 
Excellent 
SM3 0.613± 0.016 0.702± 0.011 12.738±1.958 1.146 ±0.025 23.408±1.331 
 
Excellent 
SM4 0.669 ±0.024 0.680± 0.018 11.599±1.213 1.137± 0.024 24.789±0.911 
 
Excellent 
SM5 0.598± 0.014 0.754± 0.010 11.088±1.837 1.129± 0.038 21.738±0.894 
 
Excellent 
SH1 0.668± 0.031 0.640± 0.023 10.809±1.259 1.130± 0.031 24.200±1.379 
 
Excellent 
SH2 0.567± 0.034 0.629± 0.010 12.895±1.215 1.125± 0.023 23.436±0.895 
 
Excellent 
SH3 0.618± 0.029 0.682± 0.050 12.117±2.117 1.136 ±0.030 24.962±1.611 
 
Excellent 
SH4 0.553± 0.019 0.783± 0.005 12.748±1.858 1.121± 0.015 24.485±1.380 Excellent 
SH5 0.608± 0.041 0.674± 0.008 11.597±1.273 1.142±0.015 24.475±1.281 
 
Excellent 
SS1 0.681± 0.008 0.712± 0.011 11.098±1.877 1.134± 0.022 24.216±1.247 
 
Excellent 
SS2 0.588± 0.011 0.634± 0.028 10.819±1.279 1.123± 0.034 23.418±1.231 
 
Excellent 
SS3 0.611± 0.015 0.753± 0.011 12.985±1.245 1.128± 0.034 24.769±0.812 
 
Excellent 
SS4 0.665 ±0.028 0.643± 0.022 12.117±2.119 1.127± 0.022 21.758±0.874 
 
Excellent 
SS5 0.596± 0.012 0.627± 0.011 12.728±1.948 1.144 ±0.035 24.201±1.349 
 
Excellent 
SC1 0.638± 0.034 0.689± 0.053 11.589±1.113 1.177± 0.027 23.437±0.875 
 
Excellent 
SC2 0.609± 0.011 0.752± 0.011 11.088±1.437 1.124± 0.035 24.912±1.651 
 
Excellent 
SC3 0.661 ±0.023 0.641± 0.024 10.809±1.259 1.120± 0.021 24.475±1.280 Excellent 
SC4 0.586± 0.011 0.621± 0.011 11.188±1.837 1.145± 0.024 24.455±1.381 
 
Excellent 
SC5 0.633± 0.032 0.642± 0.051 10.819±1.259 1.136± 0.021 24.226±1.217 
 
Excellent 
(± S.D represents mean standard deviation) 
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Figure 5: Comparison of natural and synthetic superdisintegrants at different concentrations Vs In vitro 
disintegration time of tablet 
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Pre-compression parameters were within prescribed limits and indicated good free flowing property. Batches which show 
best results are used for further study.  
Here, Friability is less than 1 %, Drug content was found to be in the range of 98 to 101 % which is within acceptable 
limits. Hardness of the tablets was found to be in the range of 2.5-3.0 kg/cm
2
. From the result it was found that 
formulations SM5, SH5, SS5, SC5 shown best results. 
Disintegration time of salbutamol sulphate FDT’s using mucilage of Plantago ovata, Plantago ovata husk powder, 
crosscarmellose sodium and sodium starch glycolate as superdisintegrants are shown in Figure 5.  
 
Table 6: Evaluation of compressed tablets for formulation batches 
 
F
o
rm
u
la
ti
o
n
 
C
o
d
e 
Weight 
Variation 
(% 
deviation) 
± S.D 
Hardness 
(kg/cm
2
) 
± S.D 
Thickness 
(mm) 
± S.D 
Friability 
(%) 
± S.D 
In-vitro 
DT 
(sec) 
± S.D 
Drug 
Content 
(%) 
± S.D 
Water 
Absorption 
Ratio (%) 
± S.D 
Wetting 
Time 
(sec) 
± S.D 
SM1 98.7± 
7.40 
2.53± 
0.057 
3.6± 
0.063 
0.36± 
0.007 
21± 
1.213 
98.942± 
0.12 
55.46± 
0.623 
49± 
0.164 
SM2 
 
101± 
7.6 
2.56± 
0.052 
3.4± 
0.061 
0.38± 
0.006 
19± 
1.105 
99.891± 
0.17 
53.30± 
0.635 
47± 
0.197 
SM3 98.9± 
7.41 
2.52± 
0.053 
3.2± 
0.065 
0.34± 
0.009 
16± 
1.132 
99.242± 
0.45 
55.58± 
0.659 
45± 
0.164 
SM4 98± 
7.2 
2.53±  
0.057 
3.76± 
 0.067 
0.256± 
0.002 
14.67± 
1.154 
99.64± 
0.82 
55.25± 
0.138 
43±  
2.645 
SM5 102± 
7.69 
2.55± 
0.061 
3.7± 
0.066 
0.39± 
0.015 
12± 
1.152 
98.212± 
0.23 
55.56± 
0.432 
42± 
0.136 
SH1 99.05± 
7.42 
2.56± 
0.059 
3.5± 
0.059 
0.35± 
0.016 
22± 
1.165 
99.215± 
0.26 
54.63± 
0.645 
52± 
0.187 
SH2 98± 
7.3 
2.55± 
0.051 
3.9± 
0.058 
0.33± 
0.005 
20± 
1.134 
98.220± 
0.29 
53.54± 
0.635 
50± 
0.465 
SH3 101± 
7.5 
2.59± 
0.056 
3.3± 
0.056 
0.38± 
0.042 
18± 
1.132 
98.221± 
0.26 
53.62± 
0.125 
48± 
0.152 
SH4 100± 
7.42 
2.56±  
0.057 
3.86±  
0.057 
0.461± 
0.002 
16.33± 
1.154 
99.27± 
 0.91 
54.23± 
0.703 
46± 
0.215 
SH5 98.2± 
7.36 
2.63± 
0.054 
3.4± 
0.063 
0.27± 
0.003 
14± 
1.145 
98.721± 
0.26 
53.45± 
0.345 
44± 
0.175 
SS1 98± 
7.41 
2.69± 
0.058 
3.9± 
0.065 
0.29± 
0.019 
25± 
1.123 
97.210± 
0.53 
54.54± 
0.345 
73± 
0.365 
SS2 100± 
7.43 
2.54± 
0.062 
2.9± 
0.064 
0.31± 
0.015 
23± 
1.102 
98.212± 
0.65 
55.00± 
0.345 
71± 
0.145 
SS3 99± 
7.42 
2.47± 
0.064 
3.1± 
0.066 
0.28± 
0.005 
20± 
1.131 
98.450± 
0.26 
54.64± 
0.659 
69± 
0.136 
SS4 99± 
7.43 
2.56± 
0.057 
3.76±  
0.057 
0.153± 
0.001 
18.67± 
1.52 
99.15± 
0.81 
55.213± 
0.114 
64± 
0.154 
SS5 98.7± 
7.40 
2.53± 
0.063 
3.9± 
0.059 
0.26± 
0.004 
16± 
1.326 
98.254± 
0.28 
55.64± 
0.263 
59± 
0.132 
SC1 98± 
7.41 
2.58± 
0.052 
3.4± 
0.061 
0.37± 
0.006 
23± 
1.147 
98.654± 
0.27 
54.52± 
0.645 
54± 
0.135 
SC2 99± 
7.42 
2.65± 
0.061 
3.6± 
0.063 
0.45± 
0.009 
21± 
1.132 
98.214± 
0.42 
55.62± 
0.152 
53± 
0.132 
SC3 101± 
7.57 
2.56± 
0.049 
3.5± 
0.065 
0.48± 
0.016 
19± 
1.156 
99.254± 
0.46 
55.66± 
0.356 
51± 
0.215 
SC4 99± 
7.42 
2.66±  
0.057 
3.83±  
0.057 
0.35± 
0.0152 
16.33± 
1.154 
99.12± 
 1.045 
56.71± 
0.762 
49± 
0.154 
SC5 101± 
7.57 
2.54± 
0.053 
2.9± 
0.059 
0.44± 
0.006 
14± 
1.152 
98.247± 
0.49 
54.66± 
0.236 
47± 
0.214 
(± S.D represents mean standard deviation) 
Comparative Dissolution Profiles of all the formulations 
The in-vitro dissolution profiles of prepared tablets are shown in Table 7.  
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Table 7: Comparative Dissolution Profiles of all the formulations 
 
             Time (min) 
 
Formulations 
1 
± S.D 
2 
± S.D 
4 
± S.D 
6 
± S.D 
8 
± S.D 
10 
± S.D 
SM1 74.23± 
0.11 
78.86± 
0.16 
82.24± 
0.21 
86.34± 
0.24 
91.32± 
0.26 
94.97± 
0.31 
SM2 75.36± 
0.13 
80.72± 
0.11 
83.31± 
0.16 
87.46± 
0.15 
92.23± 
0.31 
95.48± 
0.33 
SM3 76.98± 
0.14 
80.23± 
0.14 
84.63± 
0.13 
88.43± 
0.17 
93.62± 
0.12 
96.32± 
0.21 
SM4 77.87± 
0.22 
79.93± 
0.16 
85.14± 
0.31 
89.42± 
0.24 
94.31± 
0.31 
97.62± 
0.31 
SM5 78.27± 
0.12 
81.36± 
0.21 
86.21± 
0.16 
91.47± 
0.11 
95.21± 
0.31 
99.43± 
0.32 
SH1 73.23± 
0.16 
77.76± 
0.12 
81.21± 
0.15 
87.83± 
0.16 
90.32± 
0.38 
92.47± 
0.16 
SH2 75.67± 
0.17 
78.97± 
0.16 
82.13± 
0.25 
88.42± 
0.21 
92.46± 
0.32 
94.84± 
0.18 
SH3 76.43± 
0.11 
79.72± 
0.17 
82.42± 
0.21 
88.81± 
0.21 
93.12± 
0.34 
95.44± 
0.31 
SH4 76.61± 
0.21 
80.76± 
0.23 
82.83± 
0.24 
88.94± 
0.31 
93.42± 
0.24 
96.48± 
0.34 
SH5 77.21± 
0.11 
83.88± 
0.16 
86.11± 
0.35 
89.42± 
0.31 
94.47± 
0.32 
98.83± 
0.24 
SS1 74.46± 
0.13 
76.23± 
0.13 
81.42± 
0.25 
85.66± 
0.35 
91.23± 
0.32 
94.69± 
0.24 
SS2 75.42± 
0.11 
77.21± 
0.21 
82.42± 
0.21 
87.98± 
0.31 
93.42± 
0.21 
96.69± 
0.21 
SS3 76.62± 
0.16 
79.21± 
0.16 
82.89± 
0.14 
88.21± 
0.16 
94.49± 
0.19 
97.21± 
0.22 
SS4 77.29± 
0.26 
80.84± 
0.24 
83.21± 
0.24 
89.62± 
0.24 
95.12± 
0.22 
98.89± 
0.23 
SS5 78.92± 
0.11 
82.05± 
0.15 
86.87± 
0.16 
91.21± 
0.21 
97.98± 
0.23 
98.92± 
0.31 
SC1 73.73± 
0.16 
76.21± 
0.22 
81.58± 
0.31 
84.76± 
0.31 
89.82± 
0.38 
94.97± 
0.35 
SC2 75.17± 
0.13 
79.22± 
0.35 
84.56± 
0.32 
87.89± 
0.42 
91.92± 
0.41 
96.01± 
0.42 
SC3 76.38± 
0.24 
80.92± 
0.16 
85.43± 
0.35 
88.56± 
0.32 
92.66± 
0.36 
97.72± 
0.25 
SC4 77.69± 
0.11 
81.74± 
0.39 
86.92± 
0.31 
89.15± 
0.36 
93.33± 
0.34 
98.45± 
0.37 
SC5 77.93± 
0.12 
81.96± 
0.11 
87.23± 
0.21 
91.76± 
0.21 
94.21± 
0.15 
98.97± 
0.25 
(± S.D represents mean standard deviation) 
The graphical representation of in-vitro dissolution profiles of prepare tablets are shown in Figure 6 and 7.  
1) Comparative dissolution profiles of comparable formulations SM5, SH5, SC5 and SS5. 
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Figure 6: Comparative dissolution profiles of comparable formulations SM5, SH5, SC5 and SS5 
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2) Comparative dissolution profiles of all SM1-SM5, SH1-SH5, SS1-SS5, SC1-SC5 formulations 
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Figure 7: Comparative dissolution profiles of all SM1-SM5, SH1-SH5, SS1-SS5, SC1-SC5 formulations 
Among all the designed formulations SM5, SH5, SC5, SS5 
was found to be promising and displayed better results. 
The formulations SM5, SH5  10% w/w of mucilage of 
Plantago ovata and husk powder has shown comparable 
results in all respects than SC5 and SS5 formulations. In-
vitro dissolution studies on these formulations revealed 
that more than 90% drug released within 10 min. 
Stability studies 
No appreciable change in physical characteristics, the 
results concluded that fast dissolving tablets of salbutamol 
sulphate were stable during accelerated stability conditions 
up to three months. (Data not shown). 
CONCLUSION 
Finally it is concluded that disintegrating properties of the 
mucilage and husk powder of Plantago ovata has been 
studied in comparison with croscarmellose sodium and 
sodium starch glycolate. The isolated natural disintegrant 
exhibited faster drug dissolution in comparison to the 
synthetic superdisintegrants. These formulations improve 
the bioavailability and effective therapy using Plantago 
ovata mucilage as natural superdisintegrant. Therefore, in 
the years to come, there will be continued interest in 
natural mucilages and their modifications aimed at the 
development of better materials for drug delivery systems. 
ACKNOWLEDGMENTS 
The authors are grateful to Glenmark Pharmaceuticals Ltd. 
Nashik and Gayatri Psyllium husk powder, Unjha Gujarat 
for providing gift samples of Salbutamol sulphate and 
Plantago ovata husk powder also thankful to Department 
of Quality Assurance Techniques, R. G. Sapkal College of 
Pharmacy, Anjaneri, Nashik for providing the required 
facilities.  
 
REFERENCES 
1.  Augsburger L, Hoag S. Tablets: Orally Disintegrating Tablets 
and Related Tablet Formulations. Pharmaceutical Dosage 
Forms 3
rd
 Edn, Vol 2, Rational Design and Formulation; 
Informa healthcare USA, Inc; 2008. P.293-294.  
2.  Mahaveer PR, Orally disintegrating tablets: A future 
prospectus, Int J Pharm Sci Bi, 1998, 3(1),71-79. 
3.  Bhise SD, Isolation and Evaluation of Natural 
Superdisintegrant from Plantago ovata in MDTs of 
Telmisartan, IJPI’s Journal of Pharmaceutics and Cosmetology, 
2012, (2), 10-21. 
4.  Raghavendra Rao NG, Formulation and evaluation of fast 
dissolving tablets of Metoprolol tartrate using natural 
superdisintegrant, Int J Pharm Clin Res, 2010, 2 (1), 40-45. 
5.  Sharma V, Comparison of various natural superdisintegrants in 
the formulation of fast dissolving Carvedilol tablet, 
International Journal of Pharmaceutical Sciences and Research, 
2012, 3(10), 3947-3954. 
6.  Fischer MH, Nanxiong Yu, Gary R. The Gel-forming 
Polysaccharide of Psyllium Husk (Plantago ovata Forsk), 
Carbohydrate Research, 2004 339, 2009–2017. 
7.  British Pharmacopoeia 1988, Published by B.P. Commission 
Office, Vol-I, P.321-322. 
8.  The Indian Pharmacopeia 1996, Government of India, Ministry 
of Health and Family Welfare, Vol-III, Published by The Indian 
Pharmacopeia Commission, Ghaziabad, P.416. 
9.  USP-NF 2008, The Official Compendia of Standards, Asian 
Edn, Vol- 1, P.266-267,368, 675. 
10. ICH guidelines. Stability testing of new drug substances and 
products. Q1A (R2),2003. 
 
 
